Clin2
NCT07336992Possibly a fitNot yet recruiting

Seizure prevention medicine for brain bleed recovery

Spontaneous Intracerebral Hemorrhage

Part of Brain & nervous system clinical trials.

This study tests whether a medicine called levetiracetam can help people recover better after a brain bleed. Half of the participants will receive the medicine, and half will receive a placebo. The goal is to see if this medicine can help improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
580 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • You have had a brain bleed (not caused by injury, tumor, or other known cause).
  • Your symptoms started within the last 24 hours.
  • You are not currently taking seizure medication and have no history of epilepsy.
  • You do not have severe kidney disease or a history of severe mental health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06866691Recruiting· Phase 4
Seizure prevention after traumatic brain injury

This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.

Winston-Salem, North Carolina
NCT07243704Recruiting· Phase 3
Antiplatelet medicine to prevent heart events after brain bleed

This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.

Guntur, Andhra Pradesh
NCT06851078Not yet recruiting· Phase 3
Early seizure medication for brain problems in septic shock

This trial tests if giving an anti-seizure drug called levetiracetam early can help prevent or treat confusion and brain problems in people with septic shock. Septic shock is a life-threatening condition where an infection damages organs, sometimes affecting the brain.

NCT06773364Recruiting· Phase 3
Early levetiracetam and head position for stroke

This trial tests if starting a seizure medication called levetiracetam early in the ambulance, along with a specific head position, can help people having a stroke. It is for adults who show clear stroke signs within the last 2 hours and do not have other major health problems.

Suzhou, Anhui
NCT06760078Not yet recruiting· Phase 4
Early drug and blood pressure control for brain bleeding

This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.

Beijing, Beijing Municipality
NCT04573803Not yet recruiting· Phase 3
Comparing two medicines to prevent or treat seizures after head injury

This study looks at two medicines (phenytoin and levetiracetam) to see which works better for treating or preventing seizures that can happen after a traumatic brain injury. It aims to find the safest and most effective option for patients.

Hear when a new Spontaneous Intracerebral Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.